LIVN - LivaNova plc Company Long-Term Liabilities

Graphic logo of LivaNova plc (LIVN)

Supply chain control of precision parts guarantees the production stability of LivaNova PLC (LIVN). The volume of the issuer's long-term liabilities illustrates a capital management strategy, where the latest parameter stands at 0.36. Business resilience is based on non-cyclical demand in cardiology. Global scalability relies on unique patents in neurosurgery, ensuring high margins during mass production.

livanova.com (LIVN) Company Long-Term Debt: for the period 07/04/2022 - 10/30/2026
Manufactured products of LivaNova Group

High patent barriers and stringent FDA control provide LivaNova PLC (LIVN) with stability, although certification costs require significant capital. An analysis of liabilities with a maturity of over one year allows for an assessment of the business's resilience to liquidity crises, and the company's long-term borrowing statistics confirm the issuer's ability to service loans without the risk of capital degradation over the long term.